Clinical Trials
4 trialsNCT07621692 2026-06-02
Exploring Auger-Enhanced PSMA-Targeted Radioligand Therapy: A First-in-Taiwan Clinical Study of 161Tb-PSMA-I&T
National Taiwan University Hospital
Phase 1 Recruiting
NCT03874884 2025-05-14
LuPARP
Peter MacCallum Cancer Centre, Australia
Phase 1 Active not recruiting
NCT03724747 2024-11-08
Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Metastatic Castration Resistant Prostate Cancer
Bayer
Phase 1 Completed
NCT05425862 2023-12-11
REPAIR
Peter MacCallum Cancer Centre, Australia
Phase 1 Suspended